Singapore markets open in 4 hours 47 minutes
Straits Times Index
3,322.62 +14.72 (+0.45%) S&P 500
5,267.84 -39.17 (-0.74%) Dow
39,065.26 -605.78 (-1.53%) Nasdaq
16,736.03 -65.51 (-0.39%) Bitcoin USD
66,822.48 -2,981.39 (-4.27%) CMC Crypto 200
1,460.09 -42.57 (-2.83%)
Ikena Oncology, Inc. (IKNA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 65.15M |
| Enterprise value | -82.46M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 15.70 |
| Price/book (mrq) | 0.42 |
| Enterprise value/revenue | -0.28 |
| Enterprise value/EBITDA | 0.06 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.34 |
| 52-week change 3 | -78.19% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 7.3800 |
| 52-week low 3 | 1.0200 |
| 50-day moving average 3 | 1.3640 |
| 200-day moving average 3 | 2.4217 |
Share statistics
| Avg vol (3-month) 3 | 330.85k |
| Avg vol (10-day) 3 | 157.63k |
| Shares outstanding 5 | 48.26M |
| Implied shares outstanding 6 | 48.26M |
| Float 8 | 14.06M |
| % held by insiders 1 | 7.00% |
| % held by institutions 1 | 95.56% |
| Shares short (30 Apr 2024) 4 | 1.52M |
| Short ratio (30 Apr 2024) 4 | 6.83 |
| Short % of float (30 Apr 2024) 4 | 3.94% |
| Short % of shares outstanding (30 Apr 2024) 4 | 3.14% |
| Shares short (prior month 28 Mar 2024) 4 | 1.25M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,963.76% |
Management effectiveness
| Return on assets (ttm) | -29.04% |
| Return on equity (ttm) | -48.28% |
Income statement
| Revenue (ttm) | 3.85M |
| Revenue per share (ttm) | 0.09 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -74.54M |
| Net income avi to common (ttm) | -70.09M |
| Diluted EPS (ttm) | -1.5700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 157.35M |
| Total cash per share (mrq) | 3.26 |
| Total debt (mrq) | 9.74M |
| Total debt/equity (mrq) | 6.27% |
| Current ratio (mrq) | 15.85 |
| Book value per share (mrq) | 3.22 |
Cash flow statement
| Operating cash flow (ttm) | -78.26M |
| Levered free cash flow (ttm) | -44.59M |
© 2024 Yahoo. All rights reserved.